Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma
Open Access
- 31 October 2004
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 10 (10) , 698-708
- https://doi.org/10.1016/j.bbmt.2004.06.002
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myelomaBlood, 2003
- Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)Bone Marrow Transplantation, 2003
- Follow‐up of patients with progressive multiple myeloma undergoing allografts after reduced‐intensity conditioningBritish Journal of Haematology, 2003
- Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myelomaBone Marrow Transplantation, 2002
- Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myelomaBlood, 2002
- High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusionsBlood, 2001
- Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantationLeukemia, 2001
- Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centresBritish Journal of Haematology, 2001
- Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myelomaBone Marrow Transplantation, 1998
- Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma.Journal of Clinical Oncology, 1995